Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children

Pediatric Infectious Disease Journal

Volumn 15, Issue 3, 1996, Pages 192-196

  King Jr , James C ^a   Vink, Peter E ^a   Farley, John J ^a   Parks, Marie ^a   Smilie, Martha ^a   Madore, Dace ^b   Lichenstein, Richard ^a   Malinoski, Frank ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Lederle Praxis Biologicals   (United States)

Author keywords

human immunodeficiency virus; Pneumococcus; Streptococcus pneumoniae; vaccine

Indexed keywords

PNEUMOCOCCUS VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS INFECTION; VACCINATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; CONSUMER PRODUCT SAFETY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; PNEUMOCOCCAL INFECTIONS; POLYSACCHARIDES; VACCINATION; VACCINES, CONJUGATE;

EID: 0029875961     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199603000-00003     Document Type: Article

References (18)

1. 9/1 or more. JAMA 1992;268:483-8.
2. Parley JJ, King JC, Nair P, Hines SE, Tressler RL, Vink PE. Invasive pneumococcal disease among infected and uninfected children of mothers with human immunodeficiency virus infection. J Pediatr 1994;124:853-8.
3. Peters VB, Hyatt AC, Diamant EP, Hodes DS. Evaluation of prophylaxis against invasive pneumococcal infections in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1994;13:667-9.
4. Andiman WA, Mezger J, Shapiro E. Invasive bacterial infections in children born to women infected with human immunodeficiency virus type 1. J Pediatr 1994;124:846-52.
5. Opravil M, Fierz W, Matter L, Blaser J, Lüthy R. Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients. Clin Exp Immunol 1991;84:185-9.
6. Arpadi SM, Back S, O'Brien J, Janoff EN. Antibodies to pneumococcal capsular polysaccharides in children with human immunodeficiency virus infection given polyvalent pneumococcal vaccine. J Pediatr 1994;125:77-9.
7. Klein DL. Pneumococcal conjugate vaccines: review and update. Microb Drug Resistance 1995;1:49-58.
8. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR 1994;43(RR-12):1-10.
9. Quataert SA, Kirch CS, Quackenbush Wiedl LJ, et al. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S. Clin Diagn Lab Immunol 1995;2:590-7.
10. Keuls M. The use of "studentized range" in connection with an analysis of variance. Euphytics 1952;1:112-22.
11. Black SB, Shinefield HR, Lampert D, et al. Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. Pediatr Infect Dis J 1991;10:92-6.
12. Centers for Disease Control. Pneumococcal polysaccharide vaccine. MMWR 1989;38:64-8, 73-6.
13. Kale KL, King JC, Farley JJ, et al. The immunogenicity of Haemophilus influenzae type b conjugate (HbOC) vaccine in human immunodeficiency virus-infected and uninfected infants. Pediatr Infect Dis J 1995;14:350-4.
14. Borkowsky W, Steele CJ, Grubman S, Moore T, LaRussa P, Krasinski K. Antibody responses to bacterial toxoids in children infected with human immunodeficiency virus. J Pediatr 1987;110:563-6.
15. Breña AE, Cooper ER, Cabral HJ, Pelton SI. Antibody response to measles and rubella vaccine by children with HIV infection. J Acquir Immune Defic Syndr 1993;6:1125-9.
16. Rudy BJ, Rutstein RM, Pinto-Martin J. Responses to measles immunization in children infected with human immunodeficiency virus. J Pediatr 1994;125:72-4.
17. Chadwick EG, Chang G, Decker MD, Yogev R, Dimichele D, Edwards KM. Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1994;13:206-11.
18. Decker MD, Edwards KM, Bradley R, Palmer P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr 1992;120:184-9.